These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 4965252)
21. Delayed lepromin reaction and BCG application in first grade school children in S. Paulo, Brazil. Barbieri TA; Correa WM Int J Lepr Other Mycobact Dis; 1971; 39(3):750-5. PubMed ID: 4948223 [No Abstract] [Full Text] [Related]
22. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens. Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115 [TBL] [Abstract][Full Text] [Related]
23. Comparison in man of lepromins prepared from leprosy infections in man and mice. Draper P; Rees RJ; Waters MF Clin Exp Immunol; 1968 Oct; 3(8):809-16. PubMed ID: 4887859 [TBL] [Abstract][Full Text] [Related]
24. Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin. Han SH; Weiser RS; Lin YC Int J Lepr Other Mycobact Dis; 1971; 39(4):789-95. PubMed ID: 4949308 [No Abstract] [Full Text] [Related]
25. VOLE BACILLUS ANTIGEN AS A SUBSTITUTE FOR LEPROMIN. BARUA D; GHOSH S; BOSE R; GANGULI S; DAS BM Bull Calcutta Sch Trop Med; 1963 Oct; 11():157-8. PubMed ID: 14120865 [No Abstract] [Full Text] [Related]
26. IgG response to purified 65- and 70-kDa mycobacterial heat shock proteins and to antigen 85 in leprosy. Launois P; N'Diaye Niang M; Drowart A; Van Vooren JP; Sarthou JL; Lalu T; Millan J; Huygen K Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):48-54. PubMed ID: 8189089 [TBL] [Abstract][Full Text] [Related]
27. Soluble antigen of M. leprae coupled with liposomes elicits both "early" and "late" delayed hypersensitivity skin reactions. Sengupta U; Sinha S; Ramu G; Lavania RK; Gupta CM Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):45-9. PubMed ID: 3286800 [TBL] [Abstract][Full Text] [Related]
28. Lepromin retesting as a factor of lepromin test positivation. Azulay RD Int J Lepr Other Mycobact Dis; 1974; 42(4):428-30. PubMed ID: 4617721 [No Abstract] [Full Text] [Related]
29. [The lymphocyte transformation test using phytohemagglutinin, lepromin and M. leprae in lepromin-negative and positive leprosy: prognostic value compared with that of lepromin]. Pagnano PM; Bechelli LM; de Lima Filho EC Acta Leprol; 1982; (86-87):83-95. PubMed ID: 6816002 [No Abstract] [Full Text] [Related]
30. Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens. Collins FM; Morrison NE; Watson SR Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):481-9. PubMed ID: 6423556 [TBL] [Abstract][Full Text] [Related]
32. Immunological studies on leprosy: separation and evaluation of the antigens of Mycobacterium leprae. Navalkar RG; Patel PJ; Dalvi RR J Med Microbiol; 1975 May; 8(2):319-24. PubMed ID: 1095749 [TBL] [Abstract][Full Text] [Related]
33. The relation between allergy and immunity in leprosy. Maier M Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):116-39. PubMed ID: 3104515 [No Abstract] [Full Text] [Related]
34. ELISA & lepromin skin tests in household contacts of leprosy patients. Dhandayuthapani S; Anandan D; Bhatia VN Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988 [TBL] [Abstract][Full Text] [Related]
35. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria. Mustafa AS; Talwar GP Lepr India; 1978 Oct; 50(4):566-71. PubMed ID: 374875 [No Abstract] [Full Text] [Related]
36. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405 [TBL] [Abstract][Full Text] [Related]
37. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients]. Fliess EL; Ortiz MC; Corn J Hansenol Int; 1983 Jun; 8(1):9-17. PubMed ID: 6432692 [TBL] [Abstract][Full Text] [Related]
38. CHARACTERIZATION OF LEPROSY SERA WITH VARIOUS MYCOBACTERIAL ANTIGENS USING DOUBLE DIFFUSION-IN-GEL ANALYSIS. A PRELIMINARY REPORT. NAVALKAR RG; NORLIN M; OUCHTERLONY O Int Arch Allergy Appl Immunol; 1964; 25():105-13. PubMed ID: 14235471 [No Abstract] [Full Text] [Related]
39. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor. Han SH; Tsai LC; Hu SC; Loo ST Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):1-8. PubMed ID: 7004800 [TBL] [Abstract][Full Text] [Related]
40. Immunological effects of lepromin testing in Sri Lankan population groups. II. Effect on reactivity to a soluble protein antigen of Mycobacterium leprae. Pinto MR; Eriyagama NB; Pemajayantha V Lepr Rev; 1987 Sep; 58(3):227-32. PubMed ID: 3312897 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]